
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate Equities Inc. holds a positive outlook due to its strategic focus on the life science sector, which shows robust demand evidenced by improved public sector commitments and growth in various construction segments, particularly nuclear. The company's record backlog of $10.8 billion indicates strong potential for top-line growth and reflects an optimistic forecast for tenant demand, particularly in key life science markets. Additionally, anticipated improvements in biotech valuations and technology growth among AI tenants may further stimulate capital formation and rental space demand, enhancing the overall performance of Alexandria's portfolio.
Bears say
Alexandria Real Estate Equities Inc is facing significant headwinds that contribute to a negative outlook on its stock performance. Key negative indicators include a projected decline in occupancy rates driven by stagnating demand from life science tenants and an oversupply of newly built properties, which is exacerbated by funding constraints and regulatory uncertainties. Furthermore, the company has experienced operational challenges, including asset sale delays and a reduction in investment gains, which have collectively led to downward revisions in earnings expectations for 2025 and 2026.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares